Preclinical News and Research

RSS
Immunomic Therapeutics initiates JRC-LAMP-vax vaccine Phase I trial in Sugi allergy

Immunomic Therapeutics initiates JRC-LAMP-vax vaccine Phase I trial in Sugi allergy

HCT 1026 may help stem debilitating effects of muscular dystrophy

HCT 1026 may help stem debilitating effects of muscular dystrophy

UIC researchers develop transgenic Alzheimer's mouse with apoE4 gene

UIC researchers develop transgenic Alzheimer's mouse with apoE4 gene

Autism onset age predicts pattern of development in early years

Autism onset age predicts pattern of development in early years

Pevion launches Defensomes platform for broad spectrum immune enhancement

Pevion launches Defensomes platform for broad spectrum immune enhancement

FDA grants Albireo's A4250 orphan-drug designation for treatment of PFIC and PBC

FDA grants Albireo's A4250 orphan-drug designation for treatment of PFIC and PBC

Stapled Peptide oncology drug candidate exhibits robust efficacy in xenograft cancer models

Stapled Peptide oncology drug candidate exhibits robust efficacy in xenograft cancer models

EUROECHO 2012 reveals how imaging improves early diagnosis of atherosclerosis

EUROECHO 2012 reveals how imaging improves early diagnosis of atherosclerosis

Arisaph’s ARI-3037MO well tolerated in healthy male and female volunteers

Arisaph’s ARI-3037MO well tolerated in healthy male and female volunteers

Taiho Pharmaceutical announces early stage data for eight novel oncology compounds

Taiho Pharmaceutical announces early stage data for eight novel oncology compounds

BioMimetic Therapeutics reports net loss of $4.6 million for third quarter 2012

BioMimetic Therapeutics reports net loss of $4.6 million for third quarter 2012

Alnylam third quarter 2012 revenues decrease to $16.8 million

Alnylam third quarter 2012 revenues decrease to $16.8 million

Overweight, smoking add to rheumatoid arthritis risk

Overweight, smoking add to rheumatoid arthritis risk

MED1 plays a central role in mediating tamoxifen resistance in breast cancer

MED1 plays a central role in mediating tamoxifen resistance in breast cancer

Adding angiogenesis inhibitor to anti-HER2 drugs extends survival in mice with breast cancer

Adding angiogenesis inhibitor to anti-HER2 drugs extends survival in mice with breast cancer

Teva third quarter 2012 net revenues increase 14% to $5.0 billion

Teva third quarter 2012 net revenues increase 14% to $5.0 billion

Omeros initiates enrollment in OMS824 Phase 1 trial for schizophrenia and Huntington's

Omeros initiates enrollment in OMS824 Phase 1 trial for schizophrenia and Huntington's

Proposing standards and guidelines for Rett syndrome research

Proposing standards and guidelines for Rett syndrome research

Isis announces preliminary data from ISIS-STAT3 Phase 1 study on cancer

Isis announces preliminary data from ISIS-STAT3 Phase 1 study on cancer

Integra Holdings, a biopharmaceutical holding company, announced by Yissum

Integra Holdings, a biopharmaceutical holding company, announced by Yissum

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.